Back to search
FDAFDA · Food and drugs·Recall number D-0438-2024

Lansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent Heartburn, 14 capsules per bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41

Published April 17, 2024 · Recall initiated: March 27, 2024

Summary

FDA records drug Class II recall D-0438-2024, published April 17, 2024 and initiated March 27, 2024. Recalling firm: NATCO Pharma Limited; Status: Terminated; Reported quantity: 30 bottles; Lot: Lot#: 411988, Exp date: 05/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
NATCO Pharma Limited
Distributor
Nationwide in the US
Lot
Lot#: 411988, Exp date: 05/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Lansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent Heartburn, 14 capsules per bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41 recalled?

Yes. FDA published recall D-0438-2024 on April 17, 2024. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter